Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Advanced Cancer × Neoadjuvant Therapy × Clear all

Sponsor

Conditions

Breast Neoplasms 10 Lung Neoplasms 4 Esophageal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Adenocarcinoma Of Esophagus 4 Sarcoma 3 Rectal Neoplasms 3 Colorectal Neoplasms 3 Pancreatic Neoplasms 2 Osteosarcoma 2 Multiple Myeloma 2 Esophageal Squamous Cell Carcinoma 2 Carcinoma, Intraductal, Noninfiltrating 2 Vomiting 1 Urologic Neoplasms 1 Urogenital Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Teratoma 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Alveolar Soft Part 1 Rhabdomyosarcoma 1 Prostatic Neoplasms 1 Prostate Adenocarcinoma 1 Ovarian Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Neurofibrosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Nausea 1 Microsatellite Instability 1

Interventions

Nivolumab 7 linrodostat 3 Ipilimumab 3 relatlimab 2 Pemetrexed 2 tislelizumab 1 regorafenib 1 ralimetinib 1 p38 Mitogen-Activated Protein Kinases 1 efatutazone 1 abemaciclib 1 Vorinostat 1 Tamoxifen 1 Ranitidine 1 Midazolam 1 LY2603618 1 LY2584702 1 Gemcitabine 1 Fulvestrant 1 Dasatinib 1 Crizotinib 1 Cetuximab 1 Carboplatin 1 BMS-813160 1 3-(9-fluoro-2-(piperidin-1-ylcarbonyl)-1,2,3,4-tetrahydro(1,4)diazepino(6,7,1-hi)indol-7-yl)-4-imidazo(1,2-a)pyridin-3-yl-1H-pyrrole-2,5-dione 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡